To test if endogenous ADAM9 is responsible for cleaving ephrin-B1, we used two siRNAs to knock down ADAM9 in the CRC cell line HCT116, which expresses relatively high levels of ADAM9. Here, ADAM9 is linked to colorectal carcinoma.